You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Product Development of Intensity Modulation for Bolus Electron Conformal Therapy

    SBC: Decimal, LLC            Topic: 102

    Project Summary Abstract ObjectiveThis project aims to elevate electron beam therapyEBTtechnologywhich provides effective radiation treatment for superficial cancersdepthandltcmto that of other external beam radiotherapiesXRTe gx rays and protonsby bringing electron intensity modulation into the clinicChallengeApproximatelyof radiotherapy patientsin USA annuallyreceive EBT for a portion of their t ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  2. SBIR Phase II: LookingBus: Improving Public Transportation Services for the Blind

    SBC: ILANS, Inc.            Topic: I

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop an industry-ready service to improve public transportation for riders with disabilities, specifically visual impairments. The LookingBus technology helps drivers accommodate the needs of certain riders, while limiting distractions from their primary roles of driving safely. Indi ...

    SBIR Phase II 2019 National Science Foundation
  3. SBIR Phase II: Post-Quantum Cryptography in Resource-Constrained Devices

    SBC: PQSECURE TECHNOLOGIES, LLC            Topic: IT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to deliver state of the art cryptography and cybersecurity solutions to Internet of Things (IoTs) and embedded device designers, enterprise hardware and software vendors, and government contractors against the attack of classical and quantum computers. It has been widely accepted that quan ...

    SBIR Phase II 2019 National Science Foundation
  4. STTR Phase II: Deep Learning Technology For The Microscopic Analysis Of Stained Cells Using Unbiased Methods

    SBC: Stereology Resource Center, Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project is the development of software to help bioscientists analyze more tissue in less time and with higher accuracy and reproducibility. Currently, stereology studies require a trained technician to sit before a computer screen, making tedious manual counts (clicks) on hundreds to thousands of mic ...

    STTR Phase II 2019 National Science Foundation
  5. Development of a small molecule inhibitor of PAI-1 for the treatment of diffuse cutaneous systemic sclerosis

    SBC: MDI THERAPEUTICS, INC            Topic: NIAMS

    This project will provide critical preclinical data for a novel therapeutic small molecule inhibitor of plasminogen activator inhibitorPAIas a potential treatment for diffuse cutaneous systemic sclerosis with associated interstitial lung diseasedcSSc ILDSSc is a devastating disease of unknown etiology with no currently approved disease modifying treatmentslung fibrosisinterstitial lung diseaseILDi ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton

    SBC: CAYMAN CHEMICAL COMPANY, INCORPORATED            Topic: NIAMS

    PROJECT SUMMARY ABSTRACT Approximatelymillion fractures occur in the United States each yearaccounting forof all musculoskeletal injuries and leading to well overmillion hospital and physician offices visitsUp toof fractures are recalcitrant and require surgical intervention for proper healingThe weakened bones in the growing geriatric population are contributing to the rising number of cases of t ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Bioresorbable Nanoparticles for Visual Detection of Early-Stage Dental Caries

    SBC: GreenMark Biomedical Inc.            Topic: NIDCR

    PROJECT SUMMARY ABSTRACT This project responds to the need identified by NIDCR to develop improved methods to detect and predict progression of dental cariestooth decayto improve human healthWorldwidecaries is the most common chronic disease affecting almost everyoneDental disease is a major cause of economic and social loss and leads to complications including paintooth loss and even deathGeneral ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury

    SBC: Mitovation, Inc.            Topic: 101

    Neonatal hypoxia ischemia is a known cause of cerebral damage resulting from inadequate blood flow and or oxygen delivery to the infant brain beforeduringor after birthThe occurrence among hospital deliveries isperfull term births with a drastic increase among premature newbornsThe deficit in oxygen delivery to the brain results in extensive damage and severe disabilitiesRestoration of blood flow ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Repurposing of Pyrvinium Pamoate for Familial Adenomatous Polyposis (FAP)

    SBC: Stemsynergy Therapeutic            Topic: 102

    ABSTRACT Individuals with the rareinherited disorder Familial Adenomatous PolyposisFAPdevelop thousands of precancerous polyps at an early age and ultimately develop colorectal cancerCRCThe current standard of care for FAP is colectomyHoweverunavoidable side effects of colectomy are debilitatingFurthermorecolectomy does not prevent subsequent development of extra colonic intestinal tumorsthe main ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting glioblastoma stem-like cells with custom-designed viral vectors

    SBC: Lacerta Therapeutics, Inc.            Topic: 102

    GlioblastomaGBMis the most lethal form of adult brain cancers with a median survival of andltmonths despite aggressive standard chemoradiationGBM are formed by GBM stem like cellsGSCsa major contributor to tumor recurrence and a natural focus for therapeutic developmentThere are two main reasons responsible for treatment failurehigh intraand inter tumor cellular and molecular heterogeneity with mu ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government